Detalles de la búsqueda
1.
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer.
J Exp Clin Cancer Res
; 40(1): 15, 2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407715
2.
Dual inhibition of TGFß and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype.
Med Oncol
; 38(3): 24, 2021 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570712
3.
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer.
Eur J Cancer
; 138: 1-10, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32818762
4.
A dynamic link between H/ACA snoRNP components and cytoplasmic stress granules.
Biochim Biophys Acta Mol Cell Res
; 1866(12): 118529, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412274
5.
Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells.
Cancers (Basel)
; 11(10)2019 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31557914
6.
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
J Exp Clin Cancer Res
; 38(1): 41, 2019 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30691487
7.
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models.
J Exp Clin Cancer Res
; 38(1): 236, 2019 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31164152
8.
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer.
Mol Cancer Ther
; 18(4): 845-855, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30824612
9.
A functional connection between dyskerin and energy metabolism.
Redox Biol
; 14: 557-565, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29132127
10.
Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFR-dependent and in cetuximab-resistant human colorectal cancer cells.
Oncotarget
; 8(47): 82773-82783, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137301
11.
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.
Oncotarget
; 8(40): 68305-68316, 2017 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28978118
Resultados
1 -
11
de 11
1
Próxima >
>>